Oropharynx cancers caused by human papillomavirus (HPV) have risen dramatically over the years, superseding tobacco use and heavy drinking as the primary driver of new cases. Fortunately, HPV-positive ...
A circulating tumor HPV DNA blood test detected every recurrence of HPV-associated throat cancer after surgery with no false positives, outperforming standard NI-RADS imaging surveillance in a small ...
A team of scientists at Henry Ford Health + Michigan State University Health Sciences have uncovered a mechanism that allows certain head and neck cancers to hide from the immune system, a discovery ...
Please provide your email address to receive an email when new articles are posted on . A triple-therapy combination extended OS compared with historical data among certain patients with advanced ...
PDS0101, an innovative immunotherapy, targets HPV-positive cancers, including recurrent or metastatic head and neck cancer with high-risk HPV16 infection. VERSATILE-002 Phase 2 clinical trial ...
A multicenter, retrospective study analysis: Evaluating the efficacy and safety of pembrolizumab in the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma. Economic ...
Genetic testing can identify patients with HPV-positive throat cancer who may benefit from lower radiation doses, according to Cleveland Clinic research. The study, published in the Journal of ...
Long-term outcomes of phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early failure oral cancer. Ex ante budget impact analysis (BIA) of PD-1 inhibitor toripalimab ...
A University of Cincinnati physician‑researcher has opened a new phase II clinical trial to test whether patients with HPV‑positive throat cancer can safely receive lower doses of radiation. Sara ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results